Source: Euro News 24
LONDON - Pharmaceuticals giant GlaxoSmithKline said on Wednesday that net profit sank 13.5 percent in the first quarter of 2009, blaming fierce competition from generic drugmakers.
GSK said net profit tumbled to 1.13 billion pounds in the three months to March, compared with the same period of 2008.
First-quarter profit performance adversely impacted by gross margin decline due to US generic competition, one-off research and development write-offs and other back-office costs, GSK said in a statement.
Full story HERE
Fid
ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING
"It's not about what they tell you, it's about what they don't."
~ Bob Fiddaman, Author, Blogger, Researcher, Recipient of two Human Rights awards
Researching drug company and regulatory malfeasance for over 16 years
Humanist, humorist
Subscribe to:
Post Comments (Atom)
Please contact me if you would like a guest post considered for publication on my blog.
No comments: